← The Wire
IPSCNasdaq
Century Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1850119
Century Therapeutics develops "off-the-shelf" allogeneic pluripotent stem cell therapies for autoimmune diseases and cancer
red 8-K · 90d
$406M
Market cap
$2.41
Last close
+3.9%
1D
+4.8%
5D
1.9M
Volume
Price · last 39 sessions+5.2%
May 4L $2.07 · H $2.45Jun 29
120
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 16, 20268-KBylaw Amendment · Shareholder VoteJun 12, 20268-KCompany UpdateJun 8, 20268-KResults of OperationsMay 13, 202610-Q10-QMay 13, 2026DEFA14ADEFA14AApr 27, 2026DEF 14AFORM DEF 14AApr 27, 20268-KCompany UpdateMar 26, 2026424B5424B5Mar 26, 20268-KResults of Operations · Reg FD DisclosureMar 12, 202610-K10-KMar 12, 20268-KShareholder Vote · Company UpdateJan 23, 20268-KReg FD DisclosureJan 12, 20268-KMaterial Agreement · Equity IssuanceJan 8, 20268-KExecutive ChangeDec 29, 20258-KReg FD DisclosureDec 12, 20258-KExecutive Change · Reg FD DisclosureDec 9, 2025DEFA14ADEFA14ADec 2, 2025DEF 14ADEF 14ADec 2, 20258-KResults of Operations · Reg FD DisclosureNov 13, 202510-Q10-QNov 13, 20258-KDelisting NoticeAug 29, 202510-Q10-QAug 14, 20258-KExecutive Change · Results of OperationsAug 14, 20258-KExecutive Change · Exit / Disposal CostsJul 7, 20258-KShareholder VoteJun 16, 202510-Q10-QMay 15, 20258-KResults of Operations · Reg FD DisclosureMay 15, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 20258-KResults of Operations · Reg FD DisclosureMar 19, 202510-K10-KMar 19, 20258-KDelisting NoticeFeb 28, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KAgreement TerminatedDec 13, 2024SC 13GSC 13GNov 27, 20248-KResults of Operations · Company UpdateNov 5, 202410-Q10-QNov 5, 20248-KExecutive ChangeSep 26, 20248-KResults of Operations · Reg FD DisclosureAug 8, 202410-Q10-QAug 8, 20248-KCompany UpdateJul 8, 20248-K/ACompany UpdateJun 26, 20248-KShareholder VoteJun 24, 20248-KCompany UpdateJun 3, 20248-KResults of OperationsMay 9, 202410-Q10-QMay 9, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 2024SC 13GSC 13GApr 25, 2024SC 13GSC 13GApr 22, 2024SC 13GSC 13GApr 18, 20248-KAcquisition / Disposition · Equity IssuanceApr 11, 20248-KCompany UpdateApr 11, 20248-KCompany UpdateApr 9, 20248-KResults of Operations · Reg FD DisclosureMar 14, 202410-K10-KMar 14, 2024SC 13GSC 13GMar 4, 20248-KExecutive ChangeJan 19, 20248-KCompany UpdateDec 11, 20238-KCompany UpdateDec 6, 20238-KExecutive ChangeNov 14, 20238-KResults of Operations · Reg FD DisclosureNov 9, 202310-Q10-QNov 9, 20238-KCompany UpdateOct 3, 20238-KResults of Operations · Reg FD DisclosureAug 9, 202310-Q10-QAug 9, 20238-KShareholder VoteJun 29, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 20238-K/AExecutive ChangeMay 5, 20238-KAgreement TerminatedMay 5, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeApr 17, 20238-KReg FD DisclosureMar 20, 20238-KResults of OperationsMar 16, 202310-K10-KMar 16, 20238-KReg FD DisclosureMar 13, 20238-KReg FD Disclosure · Company UpdateJan 9, 2023
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 12, 2026: 2 insiders bought $80K · 2 sold $46K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Russotti GregorySee Remarks | Sell | 10,076 | $2.55 | $26K |
| Mar 12, 2026 | Carr DouglasSVP Finance & Operations | Sell | 7,043 | $2.55 | $18K |
| Mar 9, 2026 | Russotti GregorySee Remarks | Sell | 479 | $2.54 | $1K |
| Mar 9, 2026 | Carr DouglasSVP Finance & Operations | Sell | 247 | $2.54 | $627 |
| Feb 3, 2026 | Carr DouglasSVP Finance & Operations | Sell | 323 | $1.82 | $588 |
| Dec 22, 2025 | Cowan ChadChief Scientific Officer | Buy | 58,060 | $0.85 | $49K |
| Dec 12, 2025 | Pfeiffenberger BrentPresident and CEO | Buy | 52,000 | $0.58 | $30K |
| Dec 8, 2025 | Russotti GregorySee Remarks | Sell | 526 | $0.53 | $279 |
| Dec 8, 2025 | Carr DouglasSVP Finance & Operations | Sell | 257 | $0.53 | $136 |
| Nov 20, 2025 | Cowan ChadChief Scientific Officer | Sell | 5,462 | $0.50 | $3K |
| Nov 19, 2025 | Pfeiffenberger BrentPresident and CEO | Buy | 35,000 | $0.50 | $18K |
| Nov 17, 2025 | Pfeiffenberger BrentPresident and CEO | Sell | 32,456 | $0.45 | $15K |
| Nov 3, 2025 | Carr DouglasSVP Finance & Operations | Sell | 292 | $0.59 | $172 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance